Statistics on Biotechnology Use Results by sector of operation Sector Companies. Results in biotechnology for main variables and branches of activity Unidades: specified in variables Total Companies Services Industry and Construction Agriculture No. of companies carrying out R&D in Biotechnology 1.056 689 292 75 %Companies according to biotechnology used: Genetic code 36 44 18 30 %Companies according to biotechnology used: Functional units 45 50 38 20 %Companies according to biotechnology used: Cellular and tissue culturing and engineering 27 32 17 26 %Companies according to biotechnology used: Bioprocesses 47 39 69 30 %Companies according to biotechnology used: Sub-cellular organisms 8 11 4 0 %Companies according to biotechnology used: Bio-computing 25 33 10 8 %Companies according to biotechnology used: Nanobiotechnology 13 17 8 1 %Companies according to biotechnology used: Other 15 15 12 32 Companies in which biotechnology activities are: Main and/or exclusive 551 467 71 12 Companies in which biotechnology activities are: A secondary line of business 183 108 64 11 Companies in which biotechnology activities are: A tool necessary for production 323 114 157 53 %Company by field(s) of ultimate application of biotechnology use: Human Health 49 63 28 1 %Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture 20 22 13 29 %Company by field(s) of ultimate application of biotechnology use: Food products 30 25 48 15 %Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production 23 20 18 66 %Company by field(s) of ultimate application of biotechnology use: Environment 13 12 17 7 %Company by field(s) of ultimate application of biotechnology use: Industry 12 14 12 0 Personnel in R&D in biotechnology (no. of persons) 10.719 7.222 2.881 616 Personnel in R&D in biotechnology (no. of persons): Researchers 6.131 4.585 1.339 207 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants 4.588 2.637 1.542 409 Personnel in R&D in biotechnology (no. of persons): women 6.040 4.276 1.472 292 Personnel in R&D in biotechnology (no. of persons): (women) Researchers 3.411 2.569 737 104 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants 2.629 1.706 735 188 Personnel in R&D in biotechnology (FTE) 7.750,8 5.437,6 1.946,7 366,5 Personnel in R&D in biotechnology (FTE): Researchers 4.518,1 3.435,2 944,9 138 Personnel in R&D in biotechnology (FTE): Technicians and assistants 3.232,7 2.002,4 1.001,7 228,6 Personnel in R&D in biotechnology (FTE): women 4.471,4 3.236,6 1.044,4 190,4 Personnel in R&D in biotechnology (FTE): (women) Researchers 2.562,7 1.944 546,7 72 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants 1.908,7 1.292,6 497,7 118,4 Internal expenditure on R&D (thousands of euros) 679.558 485.966 166.743 26.849 1) By nature of the expense: Current expenses 634.631 450.150 159.316 25.166 1.1) Remuneration to researchers 228.857 161.501 60.869 6.486 1.2) Remuneration to technicians and assistants 104.498 57.591 40.473 6.434 1.3) Other current expenses 301.276 231.058 57.973 12.245 2) By nature of the expense: Capital expenses 44.927 35.816 7.427 1.683 2.1) Land and buildings 2.585 1.409 1.078 98 2.2) Equipment and instruments 23.569 17.290 4.766 1.513 2.3) Acquisition of specific R&D software 1.392 1.193 196 3 2.4) Otros productos de propiedad intelectual específicos para I+D 17.381 15.923 1.388 70 1) By origin of the funds: National funds 556.297 390.804 140.672 24.820 1.1) Own funds 387.010 235.228 128.729 23.053 1.2) From companies 86.025 81.958 4.067 0 1.3) Public Administration funds 74.764 65.121 7.876 1.767 1.4) From Universities 408 408 0 0 1.5) From non profit private institutions 8.090 8.090 0 0 1) By origin of the funds: Foreign funds 123.262 95.161 26.071 2.029 2.1) From EU programmes 25.125 22.065 2.915 145 2.2) Other foreign funds 98.137 73.097 23.156 1.884 Purchase of R&D services in biotechnology (thousands of euros) 147.558 85.114 61.830 614 Purchase of R&D services in biotechnology (thousands of euros): In Spain 76.875 25.665 50.761 450 Purchase of R&D services in biotechnology (thousands of euros): Abroad 70.683 59.449 11.070 165 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital 49 58 30 33 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information 14 13 13 23 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources 16 16 14 30 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain 13 16 9 7 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets 18 21 11 14 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels 18 21 10 14 %Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception 17 18 16 16 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements 37 40 34 28 %Companies that consider the following obstacles as very important considering biotechnology development: Time / cost 51 54 44 50 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting 18 19 13 22 % Companies that have requested biotechnology patents in Biotechnology 16 19 9 4 Number of patents requested 746 591 120 34 % Companies with income of an international origin related to biotechnological activities 23,3 27,7 17,3 5,7 % Turnover representing income of an international origin related to biotechnological activities 1,2 3 1,1 0,6 % Income of an international origin related to biotechnological activities distributed in: Income received from the EU 60,4 54,5 61,2 100 % Income of an international origin related to biotechnological activities distributed in: Income received from other countries 39,6 45,5 38,8 . % Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services 80,9 77,9 81,3 100 % Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain 17,8 15,5 18,4 . % Income of an international origin related with activities according to the classification: Operating source abroad 1,3 6,4 0,4 . % Income of an international origin related with activities according to the classification: Other 0,1 0,2 0 . Notas: . '.'=numeric piece of data equal to zero not resulting from rounding FTE: Full Time Equivalent Fuente: National Statistics Institute